From 2012 AACR Meeting – Resveratrol Effects Prostate Cancer Cells

Resveratrol (3,4’-trihydroxystilbene) is a natural product that can be found in significant concentrations food products like red wine, peanuts, walnuts etc. There have been some evidence that indicates that resveratrol has anti-tumorigenic activity, including in prostate cancer tumors. The precise mechanism associated with resveratrol-induced SIRT1 activation and cancer cell growth inhibition remains unclear, but we [...]

From the 2012 AACR Meeting – Pomegranate components modulate distinct pathways in prostate cancer cells

Pomegranate juice has long been in the folklore of prostate cancer survivors. Many of us use it with the goal of controlling our PSA. Most of the research evaluating the ability of pomegranate juice to control PSA has been funded by the juice manufacturers and must be looked at with skepticism. Dr. Radha Munagala and [...]

Ryan O’Neal and Warren Buffet

Two well-known celebrities were diagnosed with cancer this week – and each case illustrates the confusion that is indicative of the experience of cancer diagnosis in our broken medical system. Ryan O’neal announced his diagnosis last Friday (4/13) stating that he has stage 4 prostate cancer, but has been given a "positive" prognosis because it [...]

By |2021-02-17T11:03:08-05:00April 18th, 2012|Activism, Tools for Activists|0 Comments

From the 2012 AACR Meeting – Systemic Inflammation and Survival in Men with Prostate Cancer: Evidence from the Glasgow Inflammation Outcome Study.

I met with Dr. Kashif Shafique of the University of Glasgow who was the senior author of a research poster presented at the meeting. He and his colleagues look at the relationship between systemic inflammation and prostate cancer survival. Since there is some evidence that pre-treatment of systemic inflammation in men may be associated with [...]

Announcing Early Access To Alpharadin (Radium-233 Chloride)

I am interrupting the reviews of the AACR meeting to inform you of a very important piece of news. Men with advanced prostate cancer which is castrate resistant and who have 2 blaistic bone metastases may now have access to Alpharadin even though the FDA has not yet approved it in the United States! It [...]

Go to Top